Key result
Simulations showed that increased atrial natriuretic peptide secretion and suppressed renal sympathetic nerve activity mediate long-term blood pressure reductions during chronic baroreflex activation.
Why the study?
Does baroreflex activation lower blood pressure through mechanisms independent of renal sympathetic nerve activity in an in silico model?
Does baroreflex activation lower blood pressure through mechanisms independent of renal sympathetic nerve activity in an in silico model?
In silico modeling demonstrates that chronic baroreflex activation lowers blood pressure through both suppression of renal sympathetic nerve activity and increased atrial natriuretic peptide secretion, explaining why it remains effective after renal denervation.
No takes yet. Share an insight, caveat, or question.
May explain baroreflex efficacy after renal denervation; extends in silico mechanisms but remains hypothesis-generating for clinical translation.
Clemmer et al. (2018) studied Resistant hypertension. Baroreflex activation (simulated) vs. Blockade of RSNA suppression (simulated) was evaluated on Blood pressure lowering mechanisms. Simulations showed that increased atrial natriuretic peptide secretion and suppressed renal sympathetic nerve activity mediate long-term blood pressure reductions during chronic baroreflex activation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: